Mo Jalajel is a senior manager of pension investments at Pfizer, Inc., a major pharmaceutical company headquartered in New York City. He is responsible for the global public equity and fixed income allocations within Pfizer’s U.S. defined benefit plan. In this interview, Jalajel discusses adapting to the new fee structure for hedge funds, following a liability-driven investment philosophy and how institutions should “take every opportunity to de-risk their defined benefit plan.” He also shares career insights for young people looking to enter institutional investing.